Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group

Basit Öğe Kaydı
dc.contributor.authorÇelik, Gülfem Elif
dc.contributor.authorAydın, Ömür
dc.contributor.authorDamadoğlu, Ebru
dc.contributor.authorBaççıoğlu, Ayşe
dc.contributor.authorÖzdemir, Seçil Kepil
dc.contributor.authorBavbek, Sevim
dc.contributor.authorEdiger, Dane
dc.date.accessioned2025-01-21T16:33:53Z
dc.date.available2025-01-21T16:33:53Z
dc.date.issued2023
dc.departmentKırıkkale Üniversitesi
dc.description.abstractIntroduction of inhaled corticosteroids (ICS) has been the cornerstone of the long-term management of asthma. ICSs either alone or in combination with long-acting beta-2 agonists have been shown to be associated with favorable asthma outcomes. However, asthma con-trol is still reported to be below expectations all around the world. Research in the last decades focusing on the use of ICS/formoterol both as maintenance and as needed (maintenance and reliever therapy approach) showed improved asthma outcomes. As a result of recent developments, Turkish Asthma Guidelines group aimed to revise asthma treatment recommendations. In general, we recommend physi-cians to consider the risk factors for poor asthma outcomes, patients' compliance and expectations and then to determine a personalized treatment plan. Importantly, the use of short-acting beta-2 agonists alone as a symptom reliever in asthma patients not using regular ICS is no longer recommended. In stepwise treatment approach, we primarily recommend to use ICS-based controllers and initiate ICS as soon as possible. We define 2 different treatment tracks in stepwise approaches as maintenance and reliever therapy or fixed-dose therapy and equally recommend each track depending on the patient's risks as well as decision of physicians in a personalized manner. For both tracks, a strong recommendation was made in favor of using add-on treatments before initiating phenotype-specific treatment in step 5. A strong recommendation was also made in favor of using biologic agents and/or aspirin treatment after desensitization in severe asthma when indicated.
dc.identifier.doi10.5152/ThoracResPract.2023.23035
dc.identifier.endpage324
dc.identifier.issn2979-9139
dc.identifier.issue6
dc.identifier.pmid37909830
dc.identifier.scopus2-s2.0-85175319882
dc.identifier.scopusqualityQ4
dc.identifier.startpage309
dc.identifier.trdizinid1238673
dc.identifier.urihttps://doi.org/10.5152/ThoracResPract.2023.23035
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay1238673
dc.identifier.urihttps://hdl.handle.net/20.500.12587/23875
dc.identifier.volume24
dc.identifier.wosWOS:001117514500005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofThoracic Research and Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectAsthma; long-term management; reliever; controller; severe asthma
dc.titleStepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin/Full Text
Boyut:
8.35 MB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu